Dean Kamen, the inventor behind the iconic Segway PT, is now channeling his ingenuity into transformative health innovations. His latest bold announcement? Developing a factory to produce human organs.
Who hasn't encountered a Segway PT? This groundbreaking personal transporter propelled inventor Dean Kamen to fame upon its 2001 debut. Yet his portfolio extends far beyond, boasting inventions like the first portable insulin pump and the iBOT—a revolutionary six-wheeled mobility device that climbs stairs for people with disabilities. By 2010, Kamen held an impressive 440 patents.
Even after selling Segway in 2009, Kamen's momentum hasn't slowed. As detailed in a June 17, 2020, OneZero article, his ongoing projects include the Slingshot water purifier for underserved regions, advanced robotic prosthetics for wounded soldiers, and even a unique cannon to deploy police to building rooftops safely.
Kamen's most visionary idea yet is constructing a human organ factory—a concept that pushes the boundaries of current biotech capabilities, where organ manufacturing research is still emerging. He's spearheading a massive initiative with a $300 million budget, partially funded by the Pentagon.
At the helm of the Advanced Regenerative Manufacturing Institute (ARMI), under the U.S. Department of Defense, Kamen oversees the BioFabUSA program. Early successes are remarkable: using human bone marrow stem cells, the lab produces fully functional ligaments in just 45 days through automated processes.
Next milestones include manufacturing muscle, bone, and beta cells for insulin production— a potential breakthrough for type 1 diabetes treatment. Collaborations extend to the Texas Heart Institute for pediatric hearts. Kamen envisions these advancements scaling to reality within one to two decades.
